Cellectis S.A.CC

Cellectis S.A.

1.54USDR
+0.04+2.67%
As of today at 13:54 GMT
USD
No trades
See on Supercharts
Next report date
May 7
Report period
Q1 2025
EPS estimate
−0.15 USD
Revenue estimate
‪13.83 M‬ USD
Market capitalization
‪116.05 M‬USD
−0.37USD
‪−36.76 M‬USD
‪41.51 M‬USD
‪64.68 M‬
Beta (1Y)
0.99

About CELLECTIS


CEO
André Choulika
Headquarters
Paris
Founded
1999
FIGI
BBG0084L1XN2
Cellectis SA operates as a clinical stage biotechnological company, which engages in gene-editing platform to develop cell and gene therapies. The company was founded by David J. Sourdive and André Choulika on February 20, 1999 and is headquartered in Paris, France.
Performance
‪−24,000%‬
‪−16,000%‬
‪−8,000%‬
‪0%‬
‪8,000%‬
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪‪−51.00 M‬‬
‪‪−34.00 M‬‬
‪‪−17.00 M‬‬
‪0.00‬
‪‪17.00 M‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪‪−14.00 M‬‬
‪‪−7.00 M‬‬
‪0.00‬
‪‪7.00 M‬‬
‪‪14.00 M‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪3.50 M‬‬
‪‪7.00 M‬‬
‪‪10.50 M‬‬
‪‪14.00 M‬‬
Debt level and coverage
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪‪−60.00 M‬‬
‪0.00‬
‪‪60.00 M‬‬
‪‪120.00 M‬‬
‪‪180.00 M‬‬
Debt
Free cash flow
Cash & equivalents
Earnings
Next:May 7, 2025
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪−0.33‬
‪−0.22‬
‪−0.11‬
‪0.00‬
‪0.11‬
Actual
Estimate

No news here

Looks like there's nothing to report right now

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.